Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation
Motesanib treatment also induces significant dose-dependent reductions in tumor growth and blood vessel density of MCF-7
long-term expanded pNSCs retain high neurogenic potential and responsiveness to instructive patterning cues toward midbrain and hindbrain neuronal subtypes
39(12):6895-6901
PubMed PMID: 25412834
KN-93 Hydrochloride Catalog No.:M9578-10 The selective cyclooxygenase-2 inhibitor SC-236KN 93 is an inhibitor of Ca2+ calmodulin dependent protein kinase II (CaMK II). It inhibits fibroblast CaMK II activity and cell growth in a dose dependent manner, reversibly arrests cells in G1 and induces apoptosis. Product information CAS Number: 1956426 56 4 Molecular Weight: 537. 50 Formula: C26H30Cl2N2O4S Chemical Name: N [2 ({[(2E) 3 (4 chlorophenyl)prop 2 en 1 yl](methyl)amino}methyl)phenyl] N (2 hydroxyethyl) 4 methoxybenzene 1 sulfonamide
US$ 2417.68
US$ 2825.55
US$ 12.99
US$ 23812.47
US$ 70.00